HMGB1 and breast carcinoma: Furthermore, among patients with early-stage breast cancer who undergo NAC, those with increased HMGB1 levels had significantly better overall survival (OS) than did those with smaller HMGB1 changes, suggesting that immediate HMGB1 level augmentation is associated with better prognosis in these patients [67].